课题基金 / 基金详情

1st International Symposium on Wound Healing and Technology (WHAT I)

1st International Symposium on Wound Healing and Technology (WHAT I)
第一届伤口愈合与技术国际研讨会(WHAT I)
批准号:
7166108
负责人:
Buddy D Ratner
金额:
$2.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-10 至 2007-07-09

项目摘要

项目成果

Buddy D Ratner的其他基金

相似基金

相关文献

中文摘要
翻译
第一届伤口愈合与技术国际研讨会(WHAT I)将于2006年8月28日至30日在华盛顿大学举行,届时来自学术界和工业界的科学家、医生和工程师将齐聚一堂,概述伤口愈合的广泛技术进步和仍然存在的障碍。与其他伤口愈合会议显著不同的是,本次研讨会将强调使用生物材料、控制释放、组织工程和其他工程方法的先进伤口愈合方法。会议将重点关注材料科学家、工程师、生物学家和参与实验室和临床研究的医生之间的合作,以推进伤口愈合技术。此外,翻译研究也将以一些公司的演讲和行业科学家的观众参与为重点。伤口愈合是一个值得讨论的重要领域,因为尽管进行了数十年的基础研究,研究人员和科学家仍然对慢性伤口衰竭缺乏明确的基本认识。即使了解了伤口愈合的潜在机制,重大问题仍然存在,特别是患有慢性伤口和严重烧伤的患者。组织工程结构已经进入市场,但成本高,效益有限。不幸的是,受损的美容效果是常态。目前面临的主要挑战是在全层伤口中诱导组织再生和形成柔韧、成熟的真皮,以及控制感染。改进的生物相容性材料用于伤口护理和组织工程现在是可能的。交流和讨论这些新思想是本次会议的核心。另一项强大的技术是药物制剂的控释。迄今为止,只有一种处方药被批准用于诱导慢性伤口愈合,尽管超过15年的研发和研究了许多候选化合物。人们普遍怀疑,不能在正确的时间提供有效剂量是伤口愈合药物的主要潜在缺陷。因此,我将把临床医生思想领袖、基础学术科学家和行业领袖聚集在一起,分享大胆的想法,促进跨领域合作。伤口愈合是一个重要的讨论领域,因为尽管几十年的基础研究,我们仍然缺乏对慢性伤口衰竭的明确的基本认识。为了不仅提高我们的知识,而且为市场开发材料和技术,材料科学家、工程师、生物学家和参与实验室和临床研究的医生必须共同努力。沟通和讨论这些问题以及如何解决这些问题的新思路是本次会议的核心。
英文摘要
DESCRIPTION (provided by applicant): 1st International Symposium on Wound Healing And Technology The 1st International Symposium on Wound Healing And Technology (WHAT I), August 28-30, 2006, at the University of Washington will bring together scientists, physicians and engineers from academia and industry to overview a broad spectrum of technology advances in wound healing and the barriers that remain. WHAT I is significantly different from other wound-healing conferences in that this symposium will emphasize advanced approaches to wound healing using biomaterials, controlled release, tissue engineering, and other engineering methodologies. The conference will focus on the collaboration between materials scientists, engineers, biologists, and physicians involved in laboratory and clinical research to advance wound healing technology. Also, translational research will be spotlighted with a number of company presentations and audience participation by industrial scientists. Wound healing is a significant area for discussion because researchers and scientists still lack a clear fundamental understanding of chronic wound failures, despite decades of basic research. Even when underlying mechanisms to wound-healing are understood, significant problems persist, especially with patients suffering from chronic wounds and severe burns. Tissue-engineered constructs have entered the marketplace, but the costs are high, and the benefits limited. Compromised cosmetic outcomes are unfortunately the norm. Major challenges that remain are to induce tissue regeneration and the formation of pliable, mature dermis in full-thickness wounds and to control infection. Improved biocompatibility of materials used in wound care and tissue engineering is now possible. Communication and discussion of these new ideas is central to this meeting. Another powerful technology is the controlled-release of pharmaceutical agents. To date, only one prescription drug has been approved to induce healing of chronic wounds-despite more than 15 years of R&D and investigations of numerous candidate compounds. It is widely suspected that failure to deliver an effective dose at the correct time is a major underlying deficiency of wound-healing pharmaceuticals. Thus, WHAT I will bring clinician thought-leaders, basic academic scientists, and industrial leaders together to share bold ideas and foster cross-cutting collaboration. 1st International Symposium on Wound Healing And Technology Wound healing is a critical area for discussion because we still lack a clear fundamental understanding of chronic wound failures, despite decades of basic research. In order to advance not only our knowledge, but to develop materials and technology for the market, it is imperative that materials scientists, engineers, biologists, and physicians involved in laboratory and clinical research work together. Communication and discussion of these problems and new ideas for how we can address them are central to this meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training in Engineered Biomaterials
  • 批准号:
    6904499
  • 项目类别:
  • 资助金额:
    $18.23万
  • 财政年份:
    2003
  • 负责人:
    Buddy D Ratner
  • 依托单位:
YOUTH TAKE HEART (PHASE I & II)
  • 批准号:
    7283623
  • 项目类别:
  • 资助金额:
    $30.72万
  • 财政年份:
    2003
  • 负责人:
    Buddy D Ratner
  • 依托单位:
YOUTH TAKE HEART (PHASE I & II)
  • 批准号:
    6683535
  • 项目类别:
  • 资助金额:
    $28.22万
  • 财政年份:
    2003
  • 负责人:
    Buddy D Ratner
  • 依托单位:
YOUTH TAKE HEART (PHASE I & II)
  • 批准号:
    6944763
  • 项目类别:
  • 资助金额:
    $31.94万
  • 财政年份:
    2003
  • 负责人:
    Buddy D Ratner
  • 依托单位:
海外基金